urlc10
Vaccineexperimental
Clinical trial activity
7 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
7
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2006 (NCT00753844)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- urlc10
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00681252 | Phase 1/Phase 2 (Phase 2) | May 1, 2008 | University of Tokyo |
| NCT00673777 | Phase 1/Phase 2 (Phase 2) | May 1, 2008 | University of Tokyo |
| NCT00674258 | Phase 1/Phase 2 (Phase 2) | May 1, 2008 | University of Tokyo |
| NCT00681421 | Phase 1/Phase 2 (Phase 2) | May 1, 2008 | University of Tokyo |
| NCT00681577 | Phase 1/Phase 2 (Phase 2) | May 1, 2008 | University of Tokyo |
| NCT00632333 | Phase 1 | Feb 1, 2008 | Teikyo University, University of Tokyo |
| NCT00753844 | Phase 1 | Nov 1, 2006 | Kindai University, University of Tokyo |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Tokyo | Academic/Hospital | 7 | 5 | 2 | 2006 |
| Kindai University | Academic/Hospital | 1 | 1 | 1 | 2006 |
| Teikyo University | Academic/Hospital | 1 | 1 | 1 | 2008 |
3 organizations
Page 1 / 1